Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma
Einsele, H, Knop, S, Vogel, M, Müller, J, Kropff, M, Metzner, B, Langer, C, Sayer, H, Jung, W, Dürk, H A, Salwender, H, Wandt, H, Bassermann, F, Gramatzki, M, Rösler, W, Wolf, H-H, Brugger, W, EngelhaLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2017.83
Date:
March, 2017
File:
PDF, 828 KB
english, 2017